BCL2 and Psoriasiform dermatitis: In our study, we have used a primary antihuman antibody against Bcl-2 (rabbit monoclonal antibody from path-in-situ), and we have analyzed the expressivity of Bcl-2 in different compartments of psoriasis and psoriasiform dermatitis skin lesions.